QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Davis-Taber, R. Articles by Gopalakrishnan, M. Search for Related Content PubMed PubMed Citation Articles by Davis-Taber, R. Articles by Gopalakrishnan, M.

[¹²⁵I]A-312110, a Novel High-Affinity 1,4-Dihydropyridine ATP-sensitive K⁺ Channel Opener: Characterization and Pharmacology of Binding

Neuroscience Research (R.D.-T., E.J.M., R.J.A., K.L.W, C.-C.S., G.R., S.A.B., J.M., I.M., M.J.C., W.A.C., V.E.S., M.G.), Drug Metabolism (G.R.), and Integrative Pharmacology (J.S.M., G.A.G.), Global Pharmaceutical Research & Development, Abbott Laboratories, Abbott Park, Illinois

Although ATP-sensitive K⁺ channels continue to be explored for their therapeutic potential, developments in high-affinity radioligands to investigate native and recombinant K_ATP channels have been less forthcoming. This study reports the identification and pharmacological characterization of a novel iodinated 1,4-dihydropyridine K_ATP channel opener, [¹²⁵I]A-312110 [(9R)-9-(4-fluoro-3-¹²⁵iodophenyl)-2,3,5,9-tetrahydro-4H-pyrano[3,4-b]thieno[2,3-e]pyridin-8(7H)-one-1,1-dioxide]. Binding of [¹²⁵I]A-312110 to guinea pig cardiac (K_D = 5.8 nM) and urinary bladder (K_D = 4.9 nM) membranes were of high affinity, saturable, and to a single set of binding sites. Displacement of [¹²⁵I]A-312110 by structurally diverse potassium channel openers (KCOs) indicated a similar rank order of potency in both guinea pig cardiac and bladder membranes (K_i, heart): A-312110 (4.3 nM) > N-cyano-N'-(1,1-dimethylpropyl)-N''-3-pyridylguanidine (P1075) > (-)-N-(2-ethoxyphenyl)-N'-(1,2,3-trimethylpropyl)-2-nitroethene-1,1-diamine (Bay X 9228) > pinacidil > (-)-cromakalim > N-(4-benzoyl phenyl)-3,3,3-trifluro-2-hydroxy-2-methylpropionamine (ZD6169) > 9-(3-cyanophenyl)-3,4,6,7,9,10-hexahydro-1,8-(2H,5H)-acridinedione (ZM244085) >> diazoxide (16.7 µM). Displacement by K_ATP channel blockers, the sulfonylurea glyburide, and the cyanoguanidine N-[1-(3-chlorophenyl)cyclobutyl]-N'-cyano-N''-3-pyridinyl-guanidine (PNU-99963) were biphasic in the heart but monophasic in bladder with about a 100- to 500-fold difference in K_i values between high- and low-affinity sites. Good correlations were observed between cardiac or bladder-binding affinities of KCOs with functional activation as assessed by their respective potencies to either suppress action potential duration (APD) in Purkinje fibers or to relax electrical field-stimulated bladder contractions. Collectively, these results demonstrate that [¹²⁵I]A-312110 binds with high affinity and has an improved activity profile compared with other radiolabeled KCOs. [¹²⁵I]A-312110 is a useful tool for investigation of the molecular and functional properties of the K_ATP channel complex and for the identification, in a high throughput manner, of both novel channel blockers and openers that interact with cardiac/smooth muscle-type K_ATP channels.

Address correspondence to: Dr. Murali Gopalakrishnan, Neuroscience Research, Dept R47W, Bldg. AP9A 3rd Floor, Global Pharmaceutical Research and Development, Abbott Laboratories, 100 Abbott Park Road, Abbott Park, IL 60064-6125. E-mail: murali.gopalakrishnan{at}abbott.com